Disease characteristics of the Singapore systemic sclerosis cohort

Proceedings of Singapore Healthcare

Volumn 22, Issue 1, 2013, Pages 8-14

  Low, Andrea Hsiu Ling ^a,b   Teng, Gim Gee ^c   Law, Weng Giap ^d   Ng, Swee Cheng ^e   Santosa, Amelia ^c   Chan, Grace ^d   Lim, Anita ^c   Png, May Ee ^a   Teo, Huan Qing ^a   Lee, Ping Ting ^c   Thumboo, Julian ^a,b  

^a SINGAPORE GENERAL HOSPITAL   (Singapore)

^b Singapore Graduate Medical School   (Singapore)

^c NATIONAL UNIVERSITY HEALTH SYSTEM   (Singapore)

^d TAN TOCK SENG HOSPITAL   (Singapore)

^e KHOO TECK PUAT HOSPITAL   (Singapore)

Author keywords

Asian; Autoantibody; Chinese; Disease characteristics; Systemic sclerosis

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; CENTROMERE ANTIBODY; CORTICOSTEROID; RIBONUCLEOPROTEIN ANTIBODY; RO ANTIBODY; RO60 ANTIBODY; SCL 70 ANTIBODY; UNCLASSIFIED DRUG;

ADRENAL CORTEX INSUFFICIENCY; ADULT; ARTHRALGIA; ARTICLE; ASIAN; CHINESE; CLINICAL FEATURE; COHORT ANALYSIS; DATA BASE; DIFFUSE CUTANEOUS SYSTEMIC SCLEROSIS; DISEASE CLASSIFICATION; EARLY DIAGNOSIS; ECHOCARDIOGRAPHY; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INDIAN; INTERSTITIAL LUNG DISEASE; LIMITED CUTANEOUS SYSTEMIC SCLEROSIS; LUNG ARTERY PRESSURE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PULMONARY HYPERTENSION; RAYNAUD PHENOMENON; SCLERODERMA; SINE SCLERODERMA; SINGAPORE; SYSTEMIC SCLEROSIS; SYSTEMIC SCLEROSIS OVERLAP SYNDROME;

EID: 84886429835     PISSN: 20101058     EISSN: None     Source Type: Journal    
DOI: 10.1177/201010581302200103     Document Type: Article

References (19)

1. Reveille JD. Ethnicity and race and systemic sclerosis: How it affects susceptibility, severity, antibody genetics, and clinical manifestations. Curr Rheumatol Rep 2003,5(2):160-7.
2. Mayes MD, Lacey JV Jr., Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 2003,48(8):2246-55.
3. Nietert PJ, Mitchell HC, Bolster MB, Shaftman SR, Tilley BC, Silver RM. Racial variation in clinical and immunological manifestations of systemic sclerosis. J Rheumatol 2006,33(2):263-8.
4. Low AH, Johnson SR, Lee P. Ethnic influence on disease manifestations and autoantibodies in Chinesedescent patients with systemic sclerosis. J Rheumatol 2009,36(4):787-93.
5. Low AH, Wong S, Thumboo J, Ng SC, Lim JY, Ng X, et al. Evaluation of a new multi-parallel line immunoassay for systemic sclerosis-associated antibodies in an Asian population. Rheumatology (Oxford) 2012,51(8):1465-70.
6. Chief Statistician. Singapore Census of Population 2010 Advance Census Release. Department of Statistics, Ministry of Trade & Industry, Singapore; [updated 2010 August; cited 2012 December 7]. Available from http:// www.singstat.gov.sg/pubn/popn/c2010acr.pdf.
7. Walker JG, Pope J, Baron M, Leclercq S, Hudson M, Taillefer S, et al. The development of systemic sclerosis classification criteria. Clin Rheumatol 2007,26(9):1401-9.
8. Matucci-Cerinic M, Allanore Y, Czirjak L, Tyndall A, Muller-Ladner U, Denton C, et al. The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or rescue strategy. Ann Rheum Dis 2009,68(9):1377-80.
9. Panicheewa S, Chitrabamrung S, Verasertniyom O, Vanichaphantu M, Kraisit SO, Chiewsilp P, et al. Diffuse systemic sclerosis and related diseases in Thailand. Clin Rheumatol 1991,10(2):124-9.
10. Pagalavan L, Ong SG. Demography, clinical and laboratory features of systemic sclerosis in a Malaysian rheumatology centre. Med J Malaysia 2007,62(2):117-21.
11. Teh CL, Kuan YC, Wong JS. Systemic sclerosis in Sarawak: a profile of patients treated in the Sarawak General Hospital. Rheumatol Int 2009,29(10):1243-5.
12. Sharma VK, Trilokraj T, Khaitan BK, Krishna SM. Profile of systemic sclerosis in a tertiary care center in North India. Indian J Dermatol Venereol Leprol 2006,72(6):416-20.
13. Tamaki T, Mori S, Takehara K. Epidemiological study of patients with systemic sclerosis in Tokyo. Arch Dermatol Res 1991,283(6):366-71.
14. Meier FM, Frommer KW, Dinser R, Walker UA, Czirjak L, Denton CP, et al. Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. Ann Rheum Dis 2012,71(8):1355-60.
15. Lonzetti LS, Joyal F, Raynauld JP, Roussin A, Goulet JR, Rich E, et al. Updating the American College of Rheumatology preliminary classification criteria for systemic sclerosis: Addition of severe nailfold capillaroscopy abnormalities markedly increases the sensitivity for limited scleroderma. Arthritis Rheum 2001,44(3):735-6.
16. Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007,66(7):940-4.
17. Coral-Alvarado P, Pardo AL, Castano-Rodriguez N, Rojas-Villarraga A, Anaya JM. Systemic sclerosis: A world wide global analysis. Clin Rheumatol 2009,28(7):757-65.
18. Sharif R, Mayes MD, Nicassio PM, Gonzalez EB, Draeger H, McNearney TA, et al. Determinants of work disability in patients with systemic sclerosis: A longitudinal study of the GENISOS cohort. Semin Arthritis Rheum 2011,41(1):38-47.
19. Denton CP, Krieg T, Guillevin L, Schwierin B, Rosenberg D, Silkey M, et al. Demographic, clinical and antibody characteristics of patients with digital ulcers in systemic sclerosis: Data from the DUO Registry. Ann Rheum Dis 2012,71(5):718-21.